Imatinib in chronic myeloid leukemia elderly patients.
Department of Hematology and Clinical Oncology "Seràgnoli", S.Orsola-Malpighi Hospital, University of Bologna, Italy. gabriele.gugliotta@studio.unibo.it
Gabriele
G
Gugliotta
Fausto
F
Castagnetti
Francesca
F
Palandri
Michele
M
Baccarani
Gianantonio
G
Rosti
D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate